This report does sound like a pitch for another CR . I was hoping the developed dialouge with a potential partner(s) the may have led to a deal . IMO a lowball upfront with decent royalties would be wiser than a CR anytime soon . This is platform science with a myriad of applications that would be commercially if not technically validated by a name partner . They want a partner now they say , there talking to pharma' they say . This is not the time to play hardball as I dont see the coy in a position of strength atm .
Bio report, page-7
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.32K | 440K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 40522233 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 40065430 | 31 |
View Market Depth
| Last trade - 14.05pm 15/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |